Losartan Potassium

 

1. Generic & Brand Names

• Generic: Losartan Potassium

• Brands: Cozaar® (global), Losacar® (India), Repace®

• Combinations:

  • With diuretic: Hyzaar® (losartan + hydrochlorothiazide)

  • With amlodipine: Amturnide® (losartan + amlodipine + HCTZ)

---

2. Drug Class & Mechanism

• Class: Angiotensin II Receptor Blocker (ARB)

• Mechanism:

  • Blocks AT₁ receptors → prevents angiotensin II-induced:

    • Vasoconstriction

    • Aldosterone release

    • Cardiac remodeling

  • ↑ Bradykinin levels (less than ACEi) → lower cough risk

• Onset: 6 hours; Peak effect: 3-6 weeks

---

3. FDA-Approved Uses

Condition	Key Benefits
Hypertension (HTN)	First-line monotherapy or combo
Diabetic Nephropathy	↓ Proteinuria, slows CKD progression
Stroke Prevention	In HTN patients with LVH (LIFE trial)
Off-label:	Heart failure (if ACEi intolerant)

---

4. Dosing Regimens

Indication	Starting Dose	Target Dose	Max Dose
HTN	50 mg daily	50-100 mg daily	100 mg
Diabetic Nephropathy	50 mg daily	100 mg daily	100 mg
LVH (Stroke Prevention)	50 mg daily	100 mg daily	100 mg
Key Notes:

• Take with/without food

• Full effect in 3-6 weeks (titrate monthly)

• Renal Adjustment: No change needed

---

5. Side Effects

Common (>5%)	Serious (<1%)
Dizziness	Hyperkalemia (K⁺ >5.5 mEq/L)
Fatigue	Acute Kidney Injury
Back pain	Angioedema (rare)
No dry cough (vs. ACEi)	Hepatotoxicity

---

6. Black Box Warnings & Contraindications

• 🚫 Absolute Contraindications:

  • Pregnancy (Category D: fetal injury/death)

  • Bilateral renal artery stenosis

  • Concomitant aliskiren in diabetes

• High-Risk Groups:

  • Renal impairment: Monitor K⁺/creatinine

  • Volume depletion: Risk of hypotension

---

7. Nephroprotective Effects

Parameter	Impact
Proteinuria	↓ 30-40% in diabetic nephropathy
eGFR Decline	Slows by 2-4 mL/min/year
Mechanism	↓ Intraglomerular pressure
Evidence: RENAAL trial - ↓ ESRD risk by 28% in type 2 diabetics

---

8. Critical Drug Interactions

Medication	Risk	Action
NSAIDs	↑ AKI/hyperkalemia risk	Avoid combo; use acetaminophen
Potassium Supplements	↑ Hyperkalemia risk	Monitor K⁺ weekly
Lithium	↑ Lithium levels → toxicity	Avoid combo
Aliskiren	↑ AKI/hyperkalemia/hypotension	Contraindicated in diabetes

---

9. Special Populations

Group	Recommendation
Pregnancy	Discontinue immediately if pregnancy detected
Elderly	Start 25 mg daily (↑ hypotension risk)
Renal Impairment	Monitor K⁺/creatinine at 1-2 weeks
Hepatic Impairment	↓ Dose 50% (Child-Pugh ≥B)

---

10. Clinical Pearls

✅ Advantages:

• First-line for HTN + diabetes/proteinuria

• Better tolerability vs. ACEi (no cough)

• Uricosuric effect (↓ serum uric acid)
  ❌ Limitations:

• Less HF mortality benefit vs. ACEi

• Weak antihypertensive as monotherapy (combine with CCB/thiazide)

---

Losartan vs. Other ARBs

Parameter	Losartan	Valsartan	Telmisartan
Half-life	6-9 hours	6 hours	24 hours
Dosing	QD	QD-BID	QD
Proteinuria Reduction	+++	++	++++
Cost	$ (generic)	$$	$$$

---

Patient Counseling

1. "Take daily – even if feeling well."

2. "Avoid NSAIDs (ibuprofen, naproxen) – use Tylenol® for pain."

3. "Report immediately:

   • Dizziness/fainting (hypotension)

   • Swelling of face/lips (angioedema)

   • Muscle weakness (hyperkalemia)"

4. "Use contraception – stop drug if pregnancy suspected."

5. "Check BP weekly – bring log to appointments."

⚠️ Pregnancy Warning:

• Category D – causes fetal harm (2nd/3rd trimester)

• Switch to methyldopa/nifedipine if planning pregnancy

Prescribing Status: First-line for HTN with diabetes/CKD per ADA/KDIGO guidelines.
Cost: Generic <$0.10/dose.

Sources: ADA Standards of Care (2024), KDIGO 2022 CKD Guidelines, LIFE Trial (Lancet).